BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  Calixa Therapeutics, Inc. Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity

  March 24, 2009

   · 

  2 min read
• Deals

  Flugen, Inc. Secures Exclusive Rights to Novel Vaccine-Delivery Technology

  March 24, 2009

   · 

  3 min read
• Deals

  China Biologic Products Completes Acquisition of 35% Interest in Xi’an Huitian Blood Products Co., Ltd.

  March 24, 2009

   · 

  5 min read
• Biotech Beach

  Arena Pharmaceuticals, Inc. Obtains Equity Financing Commitment of Up to $50 Million

  March 24, 2009

   · 

  2 min read
• Drug Development

  Orexo AB Announces Phase IIa Data on OX914 in Rhinitis; OX914 Did Not Show a Statistically Significant Reduction in Patient Symptom Scores After Allergen Provocation

  March 24, 2009

   · 

  2 min read
• Business

  Hollis-Eden Pharmaceuticals Inc. Terminates CEO

  March 24, 2009

   · 

  1 min read
• BioMidwest

  GTCR Golder Rauner, LLC Forms Pharma Acquisition Platform, Actient Pharmaceuticals LLC; GTCR to Invest $200 Million in Actient

  March 24, 2009

   · 

  1 min read
• Mesa Air Group Inc., Announces Termination of Code Share Agreement with Mokulele Airlines

  March 24, 2009

   · 

  1 min read
• V Australia and Delta Air Lines Sign Interline Agreement

  March 24, 2009

   · 

  1 min read
• Southworth Development Purchases The Ritz-Carlton Golf Club at Creighton Farms

  March 24, 2009

   · 

  1 min read